International Journal of Clinical Practice. Symposium Supplement 2001-01-01

Efficacy and safety of zaleplon at peak plasma levels.

R M Mangano

Index: Int. J. Clin. Pract. Suppl. (116) , 9-13, (2001)

Full Text: HTML

Abstract

Zaleplon is a non-benzodiazepine sleep medication that shows efficacy as a sleep inducer comparable to that of other hypnotics but with significantly fewer residual effects. In addition, evaluations of psychomotor or memory function at zaleplon peak plasma levels show much less impairment than noted with other hypnotics, suggesting an improved benefit-to-risk profile for zaleplon compared with older available agents. Thus, zaleplon can be used to treat symptoms of insomnia when they occur without the concern of next-day psychomotor or memory impairment, whether administered at bedtime or later during the night. Such an approach permits physicians to reformulate their strategies for safe and effective management of sleeplessness.

Related Compounds

  • Zaleplon

Related Articles:

Cleaning up blood samples using a modified "QuEChERS" procedure for the determination of drugs of abuse and benzodiazepines by UPLC-MSMS(☆).

2014-10-01

[Forensic Sci. Int. 243 , 99-106, (2014)]

A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834.

2015-06-01

[Drug Metab. Dispos. 43 , 908-15, (2015)]

GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor.

2012-02-01

[Drug Alcohol Depend. 121(1-2) , 103-9, (2012)]

Comparison of triazolam and zaleplon for sedation of dental patients.

2005-09-01

[Dent. Today 24(9) , 64-6, 68-9, (2005)]

Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications.

2012-12-01

[Expert Opin. Drug Metab. Toxicol. 8(12) , 1609-18, (2012)]

More Articles...